QTTB Q3 2021 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+195.8% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$31M-1828.3% margin

Net Income

-$31M-1825.2% margin

EPS (Diluted)

$-9.65

QoQ Revenue Growth

-23.3%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$231M

Total Liabilities

$32M

Stockholders' Equity

$199M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$567,000	+195.8%
Gross Profit	$2M	$0	—
Operating Income	-$31M	-$28M	-8.4%
Net Income	-$31M	-$28M	-8.4%